Welcome Back
Join CoinTime
Sign in with email
Sign up with email
Check your inbox
Lonestar Heart
About
LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate functioning of a human heart.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $20M
- Industries
- Biotechnology,Genetics,Medical Device,Therapeutics
- Founded date
- Jan 1, 2009
- Number Of Employee
- 11 - 50
- Operating Status
- Active
LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF). Based on its integrated card mechanical and biomolecular technologies, the privately-held company is developing a broad portfolio of products to restore the failing heart’s structure and function in collaboration with the University of Texas Southwestern Medical Center, Texas Heart Institute, and a global network of leading clinicians. These products include Algisyl-LVR, small molecule cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the company’s proprietary biopolymer hydrogel matrix system.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 10, 2012 | Series B | $20M | 1 |
Themes Investment Partners
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Themes Investment Partners
|
Yes | Series B |
